1 false false false false false false false false false false true false false false false false false No description of principal activity 2024-04-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 07896974 2024-04-01 2025-03-31 07896974 2025-03-31 07896974 2024-03-31 07896974 2023-04-01 2024-03-31 07896974 2024-03-31 07896974 2023-03-31 07896974 core:FurnitureFittings 2024-04-01 2025-03-31 07896974 bus:LeadAgentIfApplicable 2024-04-01 2025-03-31 07896974 bus:Director2 2024-04-01 2025-03-31 07896974 core:WithinOneYear 2025-03-31 07896974 core:WithinOneYear 2024-03-31 07896974 core:ShareCapital 2025-03-31 07896974 core:ShareCapital 2024-03-31 07896974 core:RetainedEarningsAccumulatedLosses 2025-03-31 07896974 core:RetainedEarningsAccumulatedLosses 2024-03-31 07896974 bus:Director1 2024-04-01 2025-03-31 07896974 bus:SmallEntities 2024-04-01 2025-03-31 07896974 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 07896974 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 07896974 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 07896974 bus:AbridgedAccounts 2024-04-01 2025-03-31 07896974 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-04-01 2025-03-31 07896974 core:ComputerEquipment 2024-04-01 2025-03-31
STATEMENT OF CONSENT TO PREPARE ABRIDGED FINANCIAL STATEMENTS
All of the members of Medicolegal Spinal Reports Limited have consented to the preparation of the abridged statement of income and retained earnings and the abridged statement of financial position for the year ending 31 March 2025 in accordance with Section 444(2A) of the Companies Act 2006.
COMPANY REGISTRATION NUMBER: 07896974
MEDICOLEGAL SPINAL REPORTS LIMITED
FILLETED UNAUDITED ABRIDGED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 March 2025
MEDICOLEGAL SPINAL REPORTS LIMITED
REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY ABRIDGED FINANCIAL STATEMENTS OF MEDICOLEGAL SPINAL REPORTS LIMITED
YEAR ENDED 31 MARCH 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the abridged financial statements of Medicolegal Spinal Reports Limited for the year ended 31 March 2025, which comprise the abridged statement of financial position and the related notes from the company's accounting records and from information and explanations you have given us. As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at www.accaglobal.com/en/member/professional-standards/rules-standards/acca-rulebook.html. Our work has been undertaken in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/tf-163-jan-24.pdf.
LANGARD LIFFORD HALL LIMITED Accountants and Registered Auditors
Lifford Hall Lifford Lane Kings Norton Birmingham B30 3JN
29 September 2025
MEDICOLEGAL SPINAL REPORTS LIMITED
ABRIDGED STATEMENT OF FINANCIAL POSITION
31 March 2025
2025
2024
Note
£
£
£
£
Fixed assets
Tangible assets
6
318
482
Current assets
Stocks
7,196
8,516
Debtors
68,433
230,037
Cash at bank and in hand
326,601
220,514
------------
------------
402,230
459,067
Creditors: amounts falling due within one year
94,694
120,258
------------
------------
Net current assets
307,536
338,809
------------
------------
Total assets less current liabilities
307,854
339,291
------------
------------
Net assets
307,854
339,291
------------
------------
Capital and reserves
Called up share capital
200
200
Profit and loss account
307,654
339,091
------------
------------
Shareholders funds
307,854
339,291
------------
------------
These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of income and retained earnings has not been delivered.
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its abridged financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements .
MEDICOLEGAL SPINAL REPORTS LIMITED
ABRIDGED STATEMENT OF FINANCIAL POSITION (continued)
31 March 2025
These abridged financial statements were approved by the board of directors and authorised for issue on 29 September 2025 , and are signed on behalf of the board by:
K J Jackowski
Director
Company registration number: 07896974
MEDICOLEGAL SPINAL REPORTS LIMITED
NOTES TO THE ABRIDGED FINANCIAL STATEMENTS
YEAR ENDED 31 MARCH 2025
1. General Information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Lifford Hall, Lifford Lane, Kings Norton, Birmingham, B30 3JN.
2. Statement of Compliance
These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting Policies
Basis of preparation
The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The abridged financial statements are prepared in sterling, which is the functional currency of the entity.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Revenue recognition
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised: Rendering of Services Revenue from Medical report writing is recognised when the service is rendered, using the percentage of completion method on the actual services provided as a proportion of the total services to be performed.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Intangible assets
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
Patient database
-
5 years straight line basis
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Fixtures & Fittings
-
25% reducing balance
Computer Equipment
-
33% straight line
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
4. Employee Numbers
The average number of persons employed by the company during the year amounted to 1 (2024: 1 ).
5. Intangible Assets
£
Cost
At 1 April 2024 and 31 March 2025
10,000
------------
Amortisation
At 1 April 2024 and 31 March 2025
10,000
------------
Carrying amount
At 31 March 2025
------------
At 31 March 2024
------------
6. Tangible Assets
£
Cost
At 1 April 2024 and 31 March 2025
3,989
------------
Depreciation
At 1 April 2024
3,507
Charge for the year
164
------------
At 31 March 2025
3,671
------------
Carrying amount
At 31 March 2025
318
------------
At 31 March 2024
482
------------
7. Directors' Advances, Credits and Guarantees
Control relationships The company was under the control of A Jackowski and J K Jackowski throughout the year by way of their directorship and shareholdings. Included in creditors are amounts owed to the directors of £2,875 (2024: £116,780 in debtors).